Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.70012 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Maeve E Wickham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Emergency Service, Hospital, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Purpose
The magnitude of repeat exposures to culprit medications after hospital discharge is not well studied. We combined prospective cohort data with administrative health data to understand the frequency of repeat exposures to culprit medications after discharge and the risk factors for their occurrence.
Methods
This was a retrospective analysis of three prospective cohorts of patients who presented to the hospital with an adverse drug event in British Columbia, from 2008 to 2015 ( n = 849). We linked prospectively identified adverse drug events to administrative data to examine patterns of redispensing of culprit medications. We used Cox regression to assess risk factors for re‐exposure, and conducted subgroup analyses for essential vs. nonessential medications.
Results
Among 849 diagnosed adverse drug events, 45.2% had subsequent culprit medication redispensing within a year of hospital discharge. The factors associated with re‐exposures included atrial fibrillation, adverse drug event type (e.g. adverse reaction), culprit medication type, and longer historical duration of medication use.
Conclusions
Re‐exposures to culprit medications occurred in almost half of the adverse drug events diagnosed in emergency departments. Many of these were appropriate re‐exposures to essential medications for indications in which the risk of uncontrolled disease likely outweighed the risk of a repeat adverse event. More research is needed to understand re‐exposures to nonessential medications or medications with safer alternatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
- Emergency Department, Vancouver General Hospital, Vancouver, British Columbia, Canada.
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Wickham, M. E., McGrail, K. M., Law, M. R., Cragg, A., & Hohl, C. M. (2024). Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70012
Vancouver
Wickham ME, McGrail KM, Law MR, Cragg A, Hohl CM. Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.70012
BibTeX
@article{Wickham2024,
author = {Wickham, Maeve E and McGrail, Kimberlyn M and Law, Michael R and Cragg, Amber and Hohl, Corinne M},
title = {Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.70012}
}
EUVIMED